White Pine Capital’s Trinity Biotech TRIB Stock Holding History

White Pine Capital’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-370	Closed	-$92K	–	238
2019 Q2	$92K	Sell	370 -169	-31%	-$60.3K	0.03%	220
2019 Q1	$230K	Buy	539 +10	+2%	+$4.12K	0.08%	202
2018 Q4	$182K	Hold	529	–	–	0.07%	202
2018 Q3	$317K	Sell	529 -39	-7%	-$25.4K	0.11%	182
2018 Q2	$426K	Buy	568 +379	+201%	+$274K	0.15%	164
2018 Q1	$146K	Buy	+189	New	+$155K	0.05%	223
2016 Q4	–	Sell	-433	Closed	-$858K	–	214
2016 Q3	$858K	Sell	433 -25	-5%	-$46.7K	0.37%	75
2016 Q2	$778K	Sell	458 -1	-0.2%	-$1.69K	0.33%	86
2016 Q1	$803K	Buy	459 +152	+50%	+$242K	0.34%	85
2015 Q4	$542K	Buy	307 +70	+30%	+$124K	0.24%	121
2015 Q3	$407K	Sell	237 -6	-2%	-$14.5K	0.19%	152
2015 Q2	$657K	Hold	243	–	–	0.28%	109
2015 Q1	$701K	Hold	243	–	–	0.28%	110
2014 Q4	$638K	Buy	243 +70	+40%	+$181K	0.21%	124
2014 Q3	$475K	Buy	+173	New	+$562K	0.16%	150

Other funds holding TRIB

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ARM

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

White Pine Capital's TRIB Position: Q3 2019 in Review

White Pine Capital sold out of Trinity Biotech (TRIB) in Q3 2019, closing a stake of 370 shares — an estimated $92K sold.

White Pine Capital first reported a position in TRIB in Q3 2014 and held it in 15 quarters. The position peaked at $858K in Q3 2016. 28 funds tracked by Wall St. Rank hold TRIB as of Q3 2019.

White Pine Capital reported no remaining Trinity Biotech position as of Q3 2019 after selling out during the quarter.
White Pine Capital sold 370 Trinity Biotech shares in Q3 2019, an estimated $92K.
White Pine Capital first reported a position in Trinity Biotech in Q3 2014 and held it in 15 quarters.
White Pine Capital's Trinity Biotech position peaked at $858K in Q3 2016.
28 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2019.

Based on White Pine Capital's 13F filing for Q3 2019, filed 14 Nov 2019.